natgillin/translations-raw huggingface dataset:
What {PRODUCT NAME} looks like and contents of the pack {PRODUCT NAME} 10 mg chewable tablets are white to off-white with pink to purple specks with a round shape.
Izgled zdravila X in vsebina pakiranja {(Lastniško) ime} 10 mg žvečljive tablete so bele do umazano bele, okrogle žvečljive tablete z rožnatimi do vijoličastimi lisami.
NAME OF THE MEDICINAL PRODUCT {PRODUCT NAME} 40 mg chewable tablets Atorvastatin
IME ZDRAVILA {(Lastniško) ime} 40 mg žvečljive tablete atorvastatin
An 8-week, open-label study to evaluate pharmacokinetics, pharmacodynamics, and safety and tolerability of atorvastatin was conducted in children and adolescents with genetically confirmed heterozygous familial hypercholesterolemia and baseline LDL-C ≥4 mmol/L.
Pri otrocih in mladostnikih z genetsko potrjeno heterozigotno familiarno hiperholesterolemijo in izhodiščnim holesterolom LDL ≥ 4 mmol/l je bila opravljena 8-tedenska odprta študija za oceno farmakokinetike, farmakodinamike ter varnosti in prenašanja atorvastatina.
NAME OF THE MEDICINAL PRODUCT {PRODUCT NAME} 10 mg chewable tablets Atorvastatin
IME ZDRAVILA {(Lastniško) ime} 10 mg žvečljive tablete atorvastatin
NAME OF THE MEDICINAL PRODUCT [See Annex I - To be completed nationally] {PRODUCT NAME} 40 mg chewable tablet
IME ZDRAVILA [Glejte Dodatek I - Izpolni država članica] {(Lastniško) ime} 40 mg žvečljiva tableta
They are marked with 20 on one side and Pfizer on the other side.
Tablete imajo na eni strani vtisnjeno oznako "20" in na drugi "Pfizer".
They are marked with 10 on one side and Pfizer on the other side.
Tablete imajo na eni strani vtisnjeno oznako "10" in na drugi "Pfizer".
QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains 20 mg atorvastatin (as atorvastatin calcium (trihydrate)).
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena žvečljiva tableta vsebuje 20 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains 40 mg atorvastatin (as atorvastatin calcium (trihydrate)).
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena žvečljiva tableta vsebuje 40 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
They are marked with 40 on one side and Pfizer on the other side.
Tablete imajo na eni strani vtisnjeno oznako "40" in na drugi "Pfizer".
QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains 10 mg atorvastatin (as atorvastatin calcium (trihydrate)).
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena žvečljiva tableta vsebuje 10 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
Each tablet contains 20 mg of atorvastatin as atorvastatin calcium trihydrate.
Ena tableta vsebuje 20 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
Each tablet contains 40 mg of atorvastatin as atorvastatin calcium trihydrate.
Ena tableta vsebuje 40 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
Each tablet contains 10 mg of atorvastatin as atorvastatin calcium trihydrate.
Ena tableta vsebuje 10 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
STATEMENT OF ACTIVE SUBSTANCE(S) 1 chewable tablet contains 10 mg atorvastatin (as calcium salt trihydrate).
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena žvečljiva tableta vsebuje 10 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
STATEMENT OF ACTIVE SUBSTANCE(S) 1 chewable tablet contains 20 mg atorvastatin (as calcium salt trihydrate).
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena žvečljiva tableta vsebuje 20 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
STATEMENT OF ACTIVE SUBSTANCE(S) 1 chewable tablet contains 40 mg atorvastatin (as calcium salt trihydrate).
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena žvečljiva tableta vsebuje 40 mg atorvastatina (v obliki kalcijevega atorvastatinata trihidrata).
by washing your hands.
se tako, da si umijete roke.
I'm not sure my pen worked correctly.
Nisem prepričan/a, da je moj peresnik deloval pravilno.
Check to see if you have received your dose.
Preverite, ali ste prejeli vaš odmerek.
Read both sides for full instructions
Za celotna navodila preberite obe strani.
Date of latest renewal: 23 August 2019
Datum zadnjega podaljšanja: 23. avgust 2019
Your doctor may need to change your dose of these other medicines to reduce this risk.
Vaš zdravnik bo morda moral spremeniti vaš odmerek teh drugih zdravil, da bo zmanjšal tveganje.
These effects were sustained to the end of the study (104 weeks).
Ti učinki so se ohranili vse do konca študije (104. tedna).
Some patients may hear a soft click right before the second loud click.
Nekateri bolniki lahko slišijo tišji klik tik pred drugim glasnim klikom.
# From post-marketing reports.
# Iz poročil v obdobju trženja.
This is not necessary, but it may help you keep the pen steady and firm against your skin.
To ni potrebno, morda pa vam bo pomagalo, da boste peresnik držali bolj mirno in trdno na koži.
Each MACE component contributed to the reduction of MACE, as shown in Figure 2.
Vsaka komponenta MACE je prispevala k zmanjšanju MACE, kot je prikazano na sliki 2.
• in addition to other medicinal products for the treatment of diabetes.
• poleg drugih zdravil za zdravljenje sladkorne bolezni.
You should see a doctor immediately if you experience such symptoms.
Takoj morate obiskati zdravnika, če se pri vas pojavijo takšni simptomi.
COMMONLY ASKED QUESTIONS
POGOSTO ZASTAVLJENA VPRAŠANJA
The median study follow-up time was 5.4 years.
Mediani čas spremljanja v študiji je bil 5,4 leta.
Make sure the pen is locked.
Prepričajte se, da je peresnik zaklenjen.
Your dose was delivered correctly if the grey part is visible (see step 3.)
Vaš odmerek je bil pravilno dostavljen, če je sivi del viden (Glejte korak 3).
Press and hold the green injection button; you will hear a loud click.
• Pritisnite in podržite zeleni gumb za injiciranje; slišali boste glasen klik.
In each case, patients can then resume their regular once weekly dosing schedule.
V vsakem primeru lahko bolniki takrat nadaljujejo s svojim rednim urnikom odmerjanja enkrat na teden.
pharmacist or nurse.
farmacevt ali medicinska sestra.
In the event of overdose, appropriate supportive treatment should be initiated according to the patient's clinical signs and symptoms.
V primeru prevelikega odmerjanja je treba uvesti ustrezno podporno zdravljenje v skladu z bolnikovimi kliničnimi znaki in simptomi.
Did I get my complete injection?
Ali sem prejel/a celotno injekcijo?
While metoprolol tmax was delayed by 1 hour, this change was not statistically significant.
Čeprav je bil tmax metoprolola zakasnjen za 1 uro, ta sprememba ni bila statistično pomembna.
You may give them an infection or get an infection from them.
S tem bi jim lahko prenesli okužbo ali pa bi dobili okužbo od njih.
These other medicines may be medicines taken by mouth and/or insulin given by injection.
Ta druga zdravila so lahko zdravila, ki se jih jemlje prek ust in/ali insulin, ki se ga daje z injekcijo.
Patients should be informed of the characteristic symptoms of acute pancreatitis.
Bolnike je treba opozoriti na značilne simptome akutnega pankreatitisa.
The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
• Zahteve glede predložitve PSUR za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
(below 30°C) for up to a total of 14 days.
30 °C), skupno največ 14 dni.
Prepare from the refrigerator.
Pripravite iz hladilnika.
- you have severe problems with food digestion or food remaining in your stomach for longer than normal (including gastroparesis).
- imate hude težave s prebavljanjem hrane oz. če hrana zastaja v vašem želodcu dlje časa, kot je normalno (vključno z gastroparezo).
• The pen contains glass parts.
• Peresnik vsebuje steklene dele.
First degree AV block/PR interval prolongation
Atrioventrikularni blok prve stopnje/ podaljšanje intervala PR
Patients discontinued their prestudy insulin regimen at randomisation.
Bolniki so svoj predštudijski insulinski režim prekinili ob randomizaciji.
Therefore, dulaglutide does have a high degree of protection against DPP-4 inactivation (see section 5.1, Mechanism of action).
Tako ima dulaglutid visoko stopnjo zaščite pred inaktivacijo DPP-4 (glejte poglavje 5.1 Mehanizem delovanja).
I heard more than two clicks during my injection - two louder clicks and a soft one.
Med injiciranjem sem slišal/a več kot dva klika - dva glasnejša klika in enega tišjega.
• Trulicity is administered once a week.
• Zdravilo Trulicity se daje enkrat na teden.
These side effects are usually not severe.
Ti neželeni učinki običajno niso hudi.
In general these reactions were mild or moderate in severity and transient in nature.
Ti neželeni učinki so bili na splošno blagi ali zmerni in prehodne narave.
104 weeks
104 tednov
When this happens, sugar (glucose) builds up in the blood.
Ko pride do tega, se sladkor (glukoza) kopiči v krvi.
I don't know how to do a subcutaneous injection.
Ne znam izvesti subkutanega injiciranja.
Talk to your doctor about the best way to control your blood sugar while you are pregnant.
Pogovorite se z zdravnikom o najboljšem načinu za uravnavanje vašega krvnega sladkorja v nosečnosti.
The GLP-1 analog portion of dulaglutide is approximately 90 % homologous to native human GLP-1 (7-37).
Analogni del GLP-1 dulaglutida je približno 90 % homologen naravnemu humanemu GLP-1 (7-37).
For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.
Za rezultate študij glede na kombinacije, učinke na glikemično urejenost in kardiovaskularne dogodke, in na preučevano populacijo, glejte poglavja 4.4., 4.5 in 5.1.
^ Patients who withdrew from randomized treatment before 24 weeks were considered as not meeting the target
^ Bolniki, ki so z randomiziranim zdravljenjem zaključili pred 24. tednom, se smatrajo, kot da niso dosegli ciljne vrednosti.
The effect of dulaglutide on fertility in humans is unknown.
Učinek dulaglutida na plodnost pri človeku ni znan.
There were 3,114 (31.5 %) patients with established CV disease.
3114 (31,5 %) bolnikov je imelo potrjeno KV-bolezen.
You can also change the day of the week on which you inject Trulicity if necessary, as long as it has been at least 3 days since your last dose of Trulicity.
Po potrebi lahko tudi spremenite dan v tednu, na katerega si injicirate zdravilo Trulicity, a le, če so minili vsaj 3 dnevi od vašega zadnjega odmerka zdravila Trulicity.
In addition, the dulaglutide molecule was engineered to prevent the Fcγ receptor-dependent immune response and to reduce its immunogenic potential.
Poleg tega je bila molekula dulaglutida izdelana tako, da preprečuje imunski odziv, odvisen od receptorja Fcγ, in da zmanjšuje njegov imunogeni potencial.
Use of GLP-1 receptor agonists has been associated with a risk of developing acute pancreatitis.
Akutni pankreatitis Uporaba receptorskih agonistov GLP-1 je bila povezana s tveganjem nastanka akutnega pankreatitisa.
In a 6-month carcinogenicity study in transgenic mice, there was no tumorigenic response.
V 6-mesečni študiji karcinogenosti pri transgenskih miših ni bilo tumorogenega odziva.
Frequencies for events have been calculated based on their incidence in the phase II and phase III registration studies.
Pogostnosti dogodkov so bile izračunane na podlagi njihove pojavnosti v registracijskih študijah 2. in 3. faze.
Once weekly.
Enkrat tedensko.
• Do not share your syringe with anyone else.
• Injekcijske brizge ne delite z nikomer drugim.
The day of weekly administration can be changed if necessary, as long as the last dose was administered 3 or more days (72 hours) before.
Dan tedenskega odmerjanja je po potrebi mogoče spremeniti, v kolikor je bil zadnji odmerek apliciran 3 ali več dni (72 ur) pred tem.
Air bubbles are normal.
Zračni mehurčki so normalen pojav.
Week 1 Week 2 Week 3 Week 4
1. teden 2. teden 3. teden 4. teden
The safety and efficacy of dulaglutide were evaluated in nine randomised, controlled, phase III trials involving 6,193 patients with type 2 diabetes.
Varnost in učinkovitost zdravila dulaglutida sta bili ugotovljeni v devetih randomiziranih, nadziranih preskušanjih III. faze, ki so vključevala 6193 bolnikov s sladkorno boleznijo tipa 2.
The clinical relevance of these findings is currently unknown.
Pomen teh ugotovitev za človeka trenutno ni znan.
WHERE TO LEARN MORE
KJE DOBITI VEČ PODATKOV
The safety and efficacy of dulaglutide in children aged less than 18 years have not yet been established.
Varnost in učinkovitost dulaglutida pri otrocih, starih manj kot 18 let, še nista bili ugotovljeni.
Results from the long-term cardiovascular outcome study with 4949 patients randomised to dulaglutide and followed for a median of 5.4 years were consistent with these findings.
Rezultati dolgotrajne študije preizkušanja kardiovaskularnih izzidov v kateri je bilo randomizirano 4949 bolnikov na dulaglutid in spremljano v povprečju 5,4 let so bili skladni s temi ugotovitvami.
Your doctor, pharmacist or nurse can help you choose the injection site that is best for you.
• Zdravnik, farmacevt ali medicinska sestra vam lahko pomagajo izbrati mesto injiciranja, ki je najbolj ustrezno za vas.
Do I need to hold the injection button down until the injection is complete?
Ali moram držati gumb za injiciranje, dokler injiciranje ni končano?
• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
• v obliki monoterapije, kadar metformin šteje za neustreznega zaradi neprenašanja ali kontraindikacij,
the label to make sure you have the correct medicine and it has not expired.
oznako, da se boste prepričali, da imate pravo zdravilo in da se rok njegove uporabe ni iztekel.
That is the normal operation of the pen.
To je normalno delovanje peresnika.
Week 1 Week 2
1. teden 2. teden
Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body produces does not work as well as it should.
Sladkorna bolezen tipa 2 je stanje, pri katerem telo ne proizvaja dovolj insulina ali pa insulin, ki ga vaše telo proizvede, ne deluje tako dobro, kot bi moral.
3 PRESS AND HOLD
3 PRITISNITE IN DRŽITE
These engineering features result in a soluble formulation and a prolonged half-life of 4.7 days, which makes it suitable for once-weekly subcutaneous administration.
Zaradi teh tehnoloških značilnosti ima topno obliko in podaljšan razpolovni čas 4,7 dni, zaradi česar je primeren za subkutano apliciranje enkrat na teden.
Mark the day of the week you want to use your medicine to help you remember.
Označite dan v tednu, ko želite uporabiti zdravilo, da ne boste pozabili.
CHOOSE YOUR INJECTION SITE
IZBERITE SVOJE MESTO INJICIRANJA
Meta-analysis of phase II and III studies
Metaanaliza študij 2. in 3. faze
The European Medicines Agency has deferred the obligation to submit the results of studies with Trulicity in one or more subsets of the paediatric population for the treatment of type 2 diabetes mellitus (see section 4.2 for information on paediatric use).
Evropska agencija za zdravila je odložila zahtevo za predložitev rezultatov študij z zdravilom Trulicity v eni ali več podskupinah pediatrične populacije pri zdravljenju sladkorne bolezni tipa 2 (glejte poglavje 4.2 za informacije o uporabi pri otrocih).
Insert the needle into your skin at about a 45-degree angle.
Vstavite iglo v kožo pod kotom približno 45 stopinj.
Elderly No dose adjustment is required based on age (see section 5.2).
Starejši Prilagoditev odmerka na osnovi starosti ni potrebna (glejte poglavje 5.2).
Discontinuation due to an adverse event
Prekinitve zdravljenja zaradi neželenega dogodka
Glass syringe (type I).
Steklena brizga (tip I).
STORAGE AND HANDLING
RAVNANJE IN SHRANJEVANJE
Trulicity is not recommended for children and adolescents under 18 years of age because it has not been studied in these patients.
Otroci in mladostniki Uporaba zdravila Trulicity pri otrocih in mladostnikih, mlajših od 18 let, ni priporočljiva, saj pri teh bolnikih ni bila preučena.
Postprandial glucose
Postprandialna glukoza
The safety profile of Trulicity in patients with renal impairment was similar to that observed in other studies with Trulicity.
Varnostni profil zdravila Trulicity je pri bolnikih z okvarjenim delovanjem ledvic podoben tistemu, ki so ga opazili v drugih študijah z zdravilom Trulicity.
OTHER SPECIAL WARNING(S), IF NECESSARY If seal is broken before first use, contact pharmacist.
DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA Če je pred prvo uporabo pečat poškodovan, se obrnite na farmacevta.
Dulaglutide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Dulaglutid se ne sme uporabljati pri bolnikih s sladkorno boleznijo tipa 1 ali za zdravljenje diabetične ketoacidoze.
The following adverse reactions have been identified based on evaluation of the full duration of the phase II and phase III clinical studies, the long-term cardiovascular outcome study and post-marketing reports.
Naslednje neželene učinke so odkrili na podlagi evalvacije skupnega trajanja kliničnih študij 2. in 3. faze, dolgoročne študije kardiovaskularnih izidov in poročil v obdobju trženja.
SCAN THIS CODE TO LAUNCH www.trulicity.eu
SKENIRAJTE TO KODO ZA ZAGON www.trulicity.eu
The mean age was 66.2 years, the mean BMI was 32.3 kg/m², and 46.3 % of patients were female.
Povprečna starost je bila 66,2 leta, povprečni ITM 32,3 kg/m² in 46,3 % bolnikov je bilo ženskega spola.
The directions regarding syringe handling and disposal are not intended to replace local or institutional policies.
• Navodila za ravnanje z injekcijskimi brizgami in za njihovo odlaganje niso namenjena temu, da bi nadomestila lokalne smernice ali smernice zdravstvenih ustanov.
Component of a multipack, can't be sold separately.
Sestavnih delov večjega pakiranja ni mogoče prodajati ločeno.
A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
A. PROIZVAJALEC BIOLOŠKE ZDRAVILNE UČINKOVINE IN PROIZVAJALEC, ODGOVOREN ZA SPROŠČANJE SERIJ
It is important to continue to follow the advice on diet and exercise given to you by your doctor, pharmacist or nurse.
Pomembno je, da še naprej upoštevate nasvete o dieti in telesni vadbi, ki vam jih je dal vaš zdravnik, farmacevt ali medicinska sestra.
Your doctor may want to lower the dose of these other medicines to prevent you from getting low blood sugar levels (hypoglycaemia).
Vaš zdravnik bo morda želel zmanjšati odmerek teh drugih zdravil, da bo preprečil pojav nizkih ravni krvnega sladkorja pri vas (hipoglikemija).
What if the needle looks bent?
Kaj če je igla videti ukrivljena?
If you stop using Trulicity, your blood sugar levels can increase.
Če prenehate uporabljati zdravilo Trulicity, lahko ravni vašega krvnega sladkorja narastejo.
The majority of the effect on fasting blood glucose concentrations occurred by 2 weeks.
Večina učinkov na koncentracije krvne glukoze na tešče je nastopila v prvih 2 tednih.
They are most common when first starting dulaglutide but decrease over time in most patients.
Najpogostejši so ob začetku jemanja dulaglutida, vendar pri večini bolnikov postopoma izginejo.
Reduction in body weight was observed in patients treated with dulaglutide irrespective of nausea, though the reduction was numerically larger in the group with nausea.
Zmanjšanje telesne mase so opazili pri bolnikih, zdravljenih z dulaglutidom, ne glede na slabost, čeprav je bilo zmanjšanje številčno večje v skupini s slabostjo.
Please keep this in mind in all situations where you might put yourself and others at risk (e.g. driving a car or using machines).
V vseh okoliščinah, kjer bi lahko ogrozili sebe ali druge (npr. pri vožnji ali upravljanju strojev), imejte v mislih, da lahko pride do te težave.
The increased exposure may enhance the effects of dulaglutide on blood glucose levels.
Povečana izpostavljenost lahko okrepi učinke dulaglutida na ravni krvne glukoze.
- you are on dialysis as this medicine is not recommended.
- ste na dializi, ker se uporabe tega zdravila v tem primeru ne priporoča.
If you drop it on a hard surface, do not use it.
Če vam pade na trdo podlago, ga ne uporabite.
Trulicity was superior in preventing MACE compared to placebo (Figure 1).
Zdravilo Trulicity je bilo superiorno pri preprečevanju MACE v primerjavi s placebom (slika 1).
However, for patients receiving oral medicinal products requiring rapid gastrointestinal absorption or prolonged release formulations the potential for altered drug exposure should be considered.
Toda pri bolnikih, ki prejemajo zdravila za peroralno uporabo, ki zahtevajo hitro absorpcijo v prebavilih ali zdravila s podaljšanim sproščanjem, je treba upoštevati možnost spremenjene izpostavljenosti zdravilu.
Native GLP-1 has a half-life of 1.5-2 minutes due to degradation by DPP-4 and renal clearance.
Naravni GLP-1 ima razpolovni čas 1,5-2 minuti zaradi razgradnje z DPP-4 in ledvičnega očistka.
What Trulicity is and what it is used for
Kaj je zdravilo Trulicity in za kaj ga uporabljamo
You should see a doctor immediately if you experience symptoms such as rashes, itching and rapid swelling of the tissues of the neck, face, mouth or throat, hives and difficulties breathing.
Takoj morate obiskati zdravnika, če se pri vas pojavijo simptomi, kot so: izpuščaj, srbečica in hitro otekanje tkiva vratu, obraza, ust ali grla, koprivnica in težave z dihanjem.
Cardiovascular outcome study
Študija kardiovaskularnih izidov
In contrast to native GLP-1, dulaglutide is resistant to degradation by DPP-4, and has a large size that slows absorption and reduces renal clearance.
Vendar pa je za razliko od naravnega GLP-1 dulaglutid stabilen proti razgradnji z DPP-4 , in ima večjo velikost, ki upočasni absorpcijo ter zmanjša ledvični očistek.
Inject your next dose on your regular scheduled day.
Svoj naslednji odmerek si injicirajte na naslednji predpisani dan.
Injection site adverse events were reported in 1.9 % of patients receiving dulaglutide.
O reakcijah na mestu injiciranja so poročali pri 1,9 % bolnikov, ki so prejemali dulaglutid.
Sitagliptin can produce up to 80 % inhibition of DPP-4 over a 24-hour period.
Sitagliptin lahko povzroči do 80% zaviranje dipeptidil-peptidaze 4 (DPP-4) v 24-urnem obdobju.
Do not remove the pen from your skin until you hear the second louder click.
Ne umaknite peresnika s kože, dokler ne slišite drugega glasnega klika.
Your doctor should tell you how to treat low blood sugar.
Vaš zdravnik vam bo razložil, kako uravnati nizek krvni sladkor.
• When you press the green injection button, the pen will automatically insert the needle into your skin, inject the medicine, and pull back (retract) the needle after the injection is complete.
• Ko pritisnete zeleni gumb za injiciranje, bo peresnik samodejno potisnil iglo v vašo kožo, injiciral zdravilo in iglo po zaključenem injiciranju potegnil nazaj.
Trulicity that has been frozen must not be used.
Zdravila Trulicity, ki je zmrznilo, ne smete uporabljati.
- Symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating.
- simptomi nizkega krvnega sladkorja lahko vključujejo glavobol, zaspanost, šibkost, omotico, občutek lakote, zmedenost, razdražljivost, hiter srčni utrip in potenje.
Manufacturer Eli Lilly Italia S.p.A.,Via Gramsci 731/733, 50019, Sesto Fiorentino, Firenze (FI), Italy
Proizvajalec Eli Lilly Italia S.p.A.,Via Gramsci 731/733, 50019, Sesto Fiorentino, Firenze (FI), Italija
This occurs when the needle starts retracting in about 5-10 seconds.
Do tega pride, ko se igla začne umikati, po približno 5
What Trulicity is and what it is used for What you need to know before you use Trulicity How to use Trulicity
Kaj je zdravilo Trulicity in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Trulicity Kako uporabljati zdravilo Trulicity